Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of ocular adverse events at the longest · people with primary open‐angle glaucoma or ocular hypertension
1 finding from 1 review
Viral isolates · Patients being treated for cancer (leukaemia)
Prophylactic prostaglandin E (oral) led to higher viral isolates compared with placebo; GRADE not reported.
1 finding from 1 review
Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Difference in mean IOP from baseline at < 6 months · people with primary open‐angle glaucoma or ocular hypertension
1 finding from 1 review
Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · people with primary open‐angle glaucoma or ocular hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of ocular adverse events at the longest · people with primary open‐angle glaucoma or ocular hypertension
1 finding from 1 review
Dinoprostone (prostaglandin E2 analogue) · women with uterine fibroids
Interventions to reduce blood loss during myomectomy for fibroids showed no clear difference in dinoprostone (prostaglandin E2 analogue) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in vaginal delivery not achieved in 24 hours compared with vaginal prostaglandin E2 (low certainty).
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) probably leads to lower uterine hyperstimulation with FHR changes compared with vaginal prostaglandin E2 (moderate certainty).
1 finding from 1 review
Caesarean section · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in caesarean section compared with vaginal prostaglandin E2 (moderate certainty).
1 finding from 1 review
Serious neonatal morbidity or perinatal death · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) probably leads to lower serious neonatal morbidity or perinatal death compared with vaginal prostaglandin E2 (moderate certainty).
1 finding from 1 review
Serious maternal morbidity or death · third trimester induction of labour in women with a viable fetus
It is very uncertain whether balloon (Foley or ATAD) changes serious maternal morbidity or death compared with vaginal prostaglandin E2 (very low certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in apgar score < 7 at 5 minutes compared with vaginal prostaglandin E2 (low certainty).
1 finding from 1 review
Admission to neonatal intensive care unit · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with vaginal prostaglandin E2 (low certainty).
1 finding from 1 review
Failure to achieve complete abortion · women undergoing first trimester abortion
It is very uncertain whether mifepristone alone changes failure to achieve complete abortion compared with mifepristone/prostaglandin (very low certainty).
1 finding from 1 review